Cancer Predisposition Testing by Family-based Whole-genome Sequencing (WGS) in Every Child With Newly Diagnosed Cancer
Recruiting now
Conditions studied: Neoplastic Syndromes, Hereditary, Cancer, Genetic Predisposition to Disease
In brief
Assessment of the utility of family-based (trio) whole-genome sequencing for cancer predisposition testing in sequential newly diagnosed paediatric and adolescent cancer patients
Key facts
- Study ID
- NCT04903782
- Run by
- Sydney Children's Hospitals Network
- People needed
- 270
- Starts
- 2021-03-08
- Expected to finish
- 2028-06-15
- Last updated by the study team
- 2022-11-04
Who can join
Age: any, up to 21. Sex: any. Healthy volunteers: not accepted.
Where it is running
- John Hunter Children's Hospital — Newcastle, New South Wales, Australia (enrolling)
- Sydney Children's Hospital — Sydney, New South Wales, Australia (enrolling)
- The Children's Hospital at Westmead — Sydney, New South Wales, Australia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.